Medical Genetics · 2-Methylacetoacetyl-CoA Thiolase Deficiency

Biology, Diagnosis, and Look-Alikes in BKTD

At a Glance

Beta-ketothiolase deficiency is diagnosed by combining a child’s illness history with blood and urine markers, ACAT1 genetic testing, and sometimes enzyme testing. Results may be normal between crises, so a normal newborn screen or well-child test does not always rule out the disorder.

Understanding the biology of Beta-Ketothiolase Deficiency (BKTD) helps explain why the diagnosis can be so difficult to pin down. It is an autosomal recessive genetic condition, meaning a child must inherit two changed copies of the ACAT1 gene—one from each parent—to have the disorder ^[1]^[2].

The Role of the T2 Enzyme

The ACAT1 gene provides instructions for making an enzyme called mitochondrial acetoacetyl-CoA thiolase, or T2 for short ^[3]. Think of the T2 enzyme as a specialized worker in the body’s energy factory with two distinct jobs:

The Protein Job: It helps break down isoleucine, a building block of protein found in foods like meat, dairy, and beans ^[4].
The Fuel Job: It helps the body use ketones for energy. When you haven’t eaten for a while, your body burns fat to make ketones. The T2 enzyme is necessary to turn those ketones into a form of energy the heart and brain can use ^[3]^[5].

When this enzyme isn’t working, the “factory” gets backed up. Harmful acids from the half-processed protein and ketones build up in the blood and spill into the urine ^[6]^[7].

Why Diagnosis is Tricky

One of the most frustrating aspects of BKTD is that your child’s labs might look perfectly normal when they are feeling well. This is because the T2 enzyme is most needed when the body is under stress (like during an illness or a long fast) ^[8].

False Negatives: It is possible for a child to have a “normal” newborn screening or normal blood tests between crises ^[9]^[10]. If the sample was taken while the child was stable and eating well, the toxic markers might not have been high enough to be detected ^[8]^[7].
The Combined Picture: Because biochemical markers can fluctuate, diagnosis requires looking at the combined clinical, biochemical, and genetic picture. DNA sequencing of the ACAT1 gene is used to identify genetic variants, but even this is not always absolute—a variant of “uncertain significance” requires an expert geneticist to interpret alongside urine organic acids and acylcarnitines ^[11]^[1]. In some cases, specialized enzyme-activity testing on skin cells (fibroblasts) is needed ^[12].

Metabolic Look-Alikes

Doctors must carefully distinguish BKTD from other conditions that produce similar-looking lab results. A metabolic laboratory must interpret the full pattern, as these markers are not uniquely diagnostic for just one disease:

HSD17B10 Deficiency: This condition shows many of the same urine markers as BKTD but is a different genetic disorder ^[13].
Glutaric Acidemia Type I (GA-1): Sometimes, the markers for BKTD (like 2-methyl-3-hydroxybutyrate) can be confused with GA-1 on an initial screen, requiring DNA and targeted biochemical testing to separate them ^[12].
Other C5-OH Disorders: Conditions like 3-methylcrotonyl-CoA carboxylase (MCC) deficiency or HMG-CoA lyase deficiency can also elevate similar blood markers, requiring a full workup to distinguish ^[14].

Lab Marker Checklist

When you look at your child’s lab reports, you may see these technical names. These markers may support a diagnosis of BKTD, particularly when elevated during an illness, but they cannot establish or exclude it alone:

Test Type	Marker Name	What it Means in BKTD
Blood (Acylcarnitines)	C5-OH	Often elevated, but not specific only to BKTD. Can sometimes normalize between crises ^[8]^[14].
	C5:1 (Tiglylcarnitine)	May be elevated during a crisis, but often normal when stable ^[8].
	C4-OH	Usually seen primarily during an active crisis ^[8]^[15].
Urine (Organic Acids)	2-methyl-3-hydroxybutyrate	A classic signature of the blocked isoleucine pathway during a crisis ^[16]^[12].
	Tiglylglycine	Another byproduct that often spikes during illness ^[8].
	2-methylacetoacetate	Specific for BKTD, but highly unstable and disappears very quickly from samples ^[17].

Confirmation through genetic testing, or sometimes enzyme activity studies, is required to piece together the biochemical clues and ensure an accurate diagnosis ^[12]^[18].

Common questions in this guide

Can BKTD tests be normal when my child is well?

Yes. The T2 enzyme is most important during illness or prolonged fasting, when the body is breaking down protein and using ketones, so blood and urine markers may fall back toward normal between crises. A normal newborn screen or well-child test therefore does not always exclude BKTD.

What does ACAT1 genetic testing tell us about BKTD?

ACAT1 sequencing looks for changes in the gene that makes the T2 enzyme. Finding pathogenic or likely pathogenic changes in both copies supports the diagnosis, while a variant of uncertain significance usually needs review alongside the child's urine, blood, and clinical findings by a metabolic genetic specialist.

Which lab markers are checked for beta-ketothiolase deficiency?

During a crisis, blood tests may show C5-OH, C5:1, or C4-OH, and urine testing may show 2-methyl-3-hydroxybutyrate, tiglylglycine, or 2-methylacetoacetate. These findings can support BKTD, but no single marker proves or rules it out, especially when the child is stable.

How is beta-ketothiolase deficiency confirmed?

Doctors combine the child's history and examination with blood acylcarnitines, urine organic acids, and ACAT1 genetic testing. If the results remain unclear, enzyme activity can sometimes be measured in fibroblasts, which are cells grown from a small skin sample.

What other conditions can look like BKTD on lab tests?

HSD17B10 deficiency, glutaric acidemia type I, 3-methylcrotonyl-CoA carboxylase deficiency, and HMG-CoA lyase deficiency can produce overlapping markers. A metabolic laboratory may use the full pattern of results, DNA testing, and targeted biochemical tests to tell them apart.

What does autosomal recessive inheritance mean for our family?

A child develops BKTD after inheriting a changed ACAT1 copy from each parent. Parents often carry one changed copy without having the disorder, so genetic counseling can explain future-pregnancy considerations and whether other relatives may benefit from testing.

Get notified when new evidence is published on 2-methylacetoacetyl CoA thiolase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy.
Wang Y, Gao Q, Wang W, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(9)):1194-1200 doi:10.1515/jpem-2022-0158.
PMID: 35850931
2
A Novel Mutation of Beta-ketothiolase Deficiency: The First Report from Iran and Review of Literature.
Vakili R, Hashemian S
Iranian journal of child neurology 2018; (12(3)):113-121.
PMID: 30026775
3
The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target.
Goudarzi A
Life sciences 2019; (232()):116592 doi:10.1016/j.lfs.2019.116592.
PMID: 31228515
4
The significance of the ketolytic gene OXCT1 in metabolism, intracellular signaling and disease development.
Górecka K, Soboska K, Pacholczyk M, et al.
Cellular and molecular life sciences : CMLS 2026; (83(1)).
PMID: 42249126
5
Beta-ketothiolase deficiency in a Malaysian infant.
Rajan D, Constance LSL, Brandon P
The Medical journal of Malaysia 2019; (74(2)):174-175.
PMID: 31079130
6
Clinical and Mutational Characterizations of Ten Indian Patients with Beta-Ketothiolase Deficiency.
Abdelkreem E, Akella RRD, Dave U, et al.
JIMD reports 2017; (35()):59-65 doi:10.1007/8904_2016_26.
PMID: 27928777
7
Inborn errors of ketone body utilization.
Hori T, Yamaguchi S, Shinkaku H, et al.
Pediatrics international : official journal of the Japan Pediatric Society 2015; (57(1)):41-8 doi:10.1111/ped.12585.
PMID: 25559898
8
Longitudinal biochemical profiles in beta-ketothiolase deficiency: Phase-dependent diagnostic challenges and metabolic variability.
Ergun NÜ, Coşkun N, Aslantaş M, Köse MAK
Molecular genetics and metabolism 2026; (149(1-2)):110244 doi:10.1016/j.ymgme.2026.110244.
PMID: 42659719
9
Recent advances in understanding beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency.
Fukao T, Sasai H, Aoyama Y, et al.
Journal of human genetics 2019; (64(2)):99-111 doi:10.1038/s10038-018-0524-x.
PMID: 30393371
10
Mitochondrial Acetoacetyl-CoA Thiolase Deficiency: Three New Cases Detected by Newborn Screening Confirming the Significance of C4OH Elevation.
Vasco A, Berardo C, Lucchi S, et al.
International journal of neonatal screening 2025; (11(3)) doi:10.3390/ijns11030076.
PMID: 40981306
11
Beta-ketothiolase deficiency: two novel ACAT1 variants and a retrospective study of 76 cases in China.
Deng X, Li X, Liu H, et al.
Molecular genetics and metabolism 2026; (149(1-2)):110242 doi:10.1016/j.ymgme.2026.110242.
PMID: 42641357
12
Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals.
Wojcik MH, Wierenga KJ, Rodan LH, et al.
JIMD reports 2018; (39()):45-54 doi:10.1007/8904_2017_45.
PMID: 28726122
13
Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene.
Su L, Li X, Lin R, et al.
Metabolic brain disease 2017; (32(6)):2063-2071 doi:10.1007/s11011-017-0097-y.
PMID: 28875337
14
Elevated C5-hydroxy acylcarnitine in an infant girl as a result of holocarboxylase synthetase deficiency.
Nelson AT, Jones PM, Cao J
Clinica chimica acta; international journal of clinical chemistry 2024; (560()):119747 doi:10.1016/j.cca.2024.119747.
PMID: 38788890
15
C4OH-carnitine: an important marker of ketosis in patients with and without inborn errors of metabolism.
Duque Lasio ML, Zaitsev M, Hobert JA, et al.
Molecular genetics and metabolism 2025; (145(4)):109160 doi:10.1016/j.ymgme.2025.109160.
PMID: 40479756
16
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways.
Grünert SC, Sass JO
Orphanet journal of rare diseases 2020; (15(1)):106 doi:10.1186/s13023-020-01357-0.
PMID: 32345314
17
A Novel Mutation in ACAT1 Causing Beta-Ketothiolase Deficiency in a 4-Year-Old Sri Lankan Boy with Metabolic Ketoacidosis.
Manawadu TV, Jasinge E, Fernando M, et al.
Indian journal of clinical biochemistry : IJCB 2020; (35(2)):251-254 doi:10.1007/s12291-019-00851-y.
PMID: 32226259
18
Functional Analysis of Novel Variants Located in the Tetramerization Loop of ACAT1.
Xiao Y, Sasai H, Matsumoto H, et al.
The Tohoku journal of experimental medicine 2025; (267(1)):11-19 doi:10.1620/tjem.2024.J132.
PMID: 39505524

This page is for informational purposes only and does not constitute medical advice. A metabolic specialist and genetic counselor should interpret your child's results and guide next steps.